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SUMMARY  
 
 Untreated correctly and in time, hepatobiliary diseases, with extremely complex and 
intricate etiology and pathogenesis, can lead to chronic and degenerative lesions. In this 
context, antihepatotoxic action of active substances from plants can be used to reduce these 
processes. 
 The purpose of this study was to observe the efficacy of some plant-derived products 
with liver-protecting action used in the treatment of hepatobiliary diseases in dogs. 
 Thus, there were performed clinical, echographical and biochemical investigations 
upon 15 dogs of different breeds and ages, which presented clinical signs specific to 
hepatobiliary disorders (Codreanu and Diaconescu, 2003). The main modality to investigate 
liver function was the biochemical exam of blood, which was performed at the beginning of 
treatment (Dial, 1995; Kramer and Hoffman, 1997). The used phytotherapeutic commercial 
products were Liv 52, Silimarina and Farcovit B12. These products were administered in doses 
of 1-2 tablets/10 kg b.w. for different periods of time (30-91 days), until the disappearance of 
clinical signs; at that time, there were repeated biochemical and echographic exams. The main 
biochemical parameters that were studied were: GPT (ALT), GOT (AST), GGT, alkaline 
phosphatase (AP), cholesterol and triglycerides. 
 After using the selected phytotherapeutic products, the values of the investigated 
parameters are presented in table 1. 
Table 1 
The variation of biochemical parameters before and after the treatment  
Liv 52 Silimarina  Farcovit B12 Product 
 
Parameter 
 Physiological  
values 
Before 
treatment 
(average) 
After 
treatment 
(average) 
Before 
treatment 
(average) 
After 
treatment 
(average) 
Before 
treatment 
(average) 
After 
treatment 
(average) 
GPT/ALT (U/l) 8.2-57.5 111.2 62.5 127.7 69.6 119.6 61.6 
GOT/AST (U/l) 8.9-98.5 64.8 32.3 54.8 41.2 54.2 31.4 
GGT (U/l) 1.0-9.7 15.66 9.32 13.3 9.2 9.7 7.7 
AP (U/l) 10.6-100.7 456.4 276.2 214.8 178.2 252.6 192.8 
Cholesterol 
(mg/dl) 
115.6-253.7 270.8 181.4 214.4 150.6 270.5 178.6 
Triglycerides 
(mg/dl) 
20-150 133.4 94.6 114.6 81.4 139.2 104.6 
The obtained results showed that the efficacy of the three products was similar and it 
was influenced both by the dosage and the period of administration.  
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